Stargardt disease (STGD1) is the most common cause of juvenile macular dystrophy. Mutations in the adenosine triphosphate binding cassette transporter alpha 4 subunit (ABCA4) gene cause this condition and are inherited in an autosomal recessive pattern. STGD1 is a heterogeneous disease with many clinical presentations and varying rates of the age of onset and disease progression. Patients can easily be misdiagnosed and subjected to multiple investigations like neuroimaging, lumbar punctures, and therapies. Multimodal imaging is required to establish an early diagnosis. Several therapeutic options are currently under evaluation; however, they have yet to receive the United States Food and Drug Administration recommendation. This activity reviews the pathophysiology, presenting clinical features, various imaging modalities, differential diagnosis, and the various treatment modalities of STGD1.
- Provider:StatPearls, LLC
- Activity Link: https://www.statpearls.com/ArticleLibrary/viewarticle/147980
- Start Date: 2023-09-01 05:00:00
- End Date: 2023-09-01 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.5 hours
Nursing: 1.5 hours
Pharmacy: 1.5 hours - MOC Credit Details: ABS - 1.5 Point; Credit Type(s): Accredited CME (ABS)
ABPATH - 1.5 Point; Credit Type(s): Lifelong Learning (ABPATH)
ABS - 1.5 Point; Credit Type(s): Self-Assessment (ABS)
ABP - 1.5 Point; Credit Type(s): Lifelong Learning and Self-Assessment (ABP) - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Variable
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: General Pediatrics, General Surgery, Molecular Genetic Pathology